ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Cyclophilin-D Inhibition Mitigates Cardiac Allograft Ischemia-Reperfusion Injury and Rejection

A. Qamar1, P. McLeod2, J. Jiang2, X. Huang2, A. M. Jevnikar2, Z. Zhang2

1Pathology & Laboratory Medicine, University of Western Ontario, London, ON, Canada, 2London Health Sciences Center, London, ON, Canada

Meeting: 2020 American Transplant Congress

Abstract number: B-353

Keywords: Apoptosis, Endothelial cells, Graft survival, Necrosis

Session Information

Session Name: Poster Session B: Ischemia Reperfusion & Organ Rehabilitation

Session Type: Poster Session

Date: Saturday, May 30, 2020

Session Time: 3:15pm-4:00pm

 Presentation Time: 3:30pm-4:00pm

Location: Virtual

*Purpose: The clinical relevance of ischemia-reperfusion injury (IRI) in the context of organ transplantation is well-established. IRI is associated with various forms of programmed cell death (PCD), of which necroptosis is particularly significant. Necroptosis is an inflammatory form of PCD that promotes alloimmunity and adversely affects allograft viability and function. We have recently shown the role of Cyclophilin D (CypD), a critical mediator of mitochondrial permeability transition pore (mPTP) formation, in microvascular endothelial cell (MVEC) necroptosis. In this study, we investigated the downstream mechanism of CypD-mediated necroptosis. Furthermore, we studied the role of CypD inhibition in mitigating IRI-induced allograft injury and the subsequent alloimmune response in a clinically relevant scenario of cardiac transplantation.

*Methods: To model ischemic insult in vitro, MVECs were exposed to hypoxia in glucose-free medium. To model the reperfusion event, MVECs were then transferred to a normoxic incubator in cell culture medium. Cell death was monitored by live-cell imaging and flow cytometry. For in vivo studies, C57BL/6 heart grafts were subjected to cold ischemia storage before transplantation into BALB/c mice. Histopathological grading of IRI and allograft rejection was done by a pathologist.

*Results: Our data indicate that inhibition of caspases during hypoxia decreases apoptosis but increases necroptosis and that inhibition of CypD attenuates hypoxia-induced necroptosis (n=3; p≤0.001). Interestingly, we found that hypoxia-induced necroptosis involves apoptosis-inducing factor (AIF) translocation to the nucleus and that AIF silencing also attenuates hypoxia-induced necroptosis (n=3; p≤0.001). Our in vivo studies confirm that CypD deficiency in ischemia-treated donor hearts mitigates IRI and allograft rejection (n=8; p=0.008).

*Conclusions: Our findings suggest that CypD inhibition following transplantation substantially attenuates necroptosis and mitigates allograft injury and the subsequent alloimmune response. Our data also indicate that AIF may be the downstream effector molecule that executes IRI-induced DNA damage in necroptosis. As such, targeting mitochondrial permeability may be a plausible approach in formulating therapeutic strategies aimed at improving allograft viability and function.

 border=

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Qamar A, McLeod P, Jiang J, Huang X, Jevnikar AM, Zhang Z. Cyclophilin-D Inhibition Mitigates Cardiac Allograft Ischemia-Reperfusion Injury and Rejection [abstract]. Am J Transplant. 2020; 20 (suppl 3). https://atcmeetingabstracts.com/abstract/cyclophilin-d-inhibition-mitigates-cardiac-allograft-ischemia-reperfusion-injury-and-rejection/. Accessed May 11, 2025.

« Back to 2020 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences